Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. [electronic resource]
Producer: 20121029Description: 2304-13 p. digitalISSN:- 1524-4636
- Adult
- Analysis of Variance
- Biomarkers -- blood
- Blood Urea Nitrogen
- C-Reactive Protein -- metabolism
- Cardiac Surgical Procedures -- adverse effects
- Cardiotonic Agents -- therapeutic use
- Caveolin 1 -- metabolism
- China
- Creatine Kinase -- blood
- Creatinine -- blood
- Female
- HSP90 Heat-Shock Proteins -- metabolism
- Heart Injuries -- blood
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Interleukin-6 -- blood
- Interleukin-8 -- blood
- Male
- Middle Aged
- Myocardium -- metabolism
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type III -- metabolism
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- Simvastatin -- administration & dosage
- Single-Blind Method
- Stroke Volume -- drug effects
- Time Factors
- Treatment Outcome
- Troponin T -- blood
- Ultrasonography
- Ventricular Function, Left -- drug effects
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.